(S)-Baxdrostat

• CAT Number: I043585
• CAS Number: 1428652-16-7
• Molecular Formula: C22H25N3O2
• Molecular Weight: 363.45
• Purity: ≥95%
• Synonyms: N-[(8S)-4-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl]propanamide
• InChI: InChI=1S/C22H25N3O2/c1-3-21(26)24-19-6-4-5-16-17(12-23-13-18(16)19)14-7-9-20-15(11-14)8-10-22(27)25(20)2/h7,9,11-13,19H,3-6,8,10H2,1-2H3,(H,24,26)/t19-/m0/s1
• InChIKey: VDEUDSRUMNAXJG-IBGZPJMESA-N
• SMILES: CCC(=O)N[C@H]1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C

(S)-Baxdrostat（Cat No.:I043585）is a selective inhibitor of aldosterone synthase, an enzyme involved in the production of aldosterone, a hormone that regulates blood pressure and electrolyte balance. By inhibiting aldosterone synthesis, (S)-Baxdrostat aims to reduce aldosterone levels, helping to manage conditions such as hyperaldosteronism, hypertension, and heart failure. This compound is being studied for its potential therapeutic benefits in treating diseases related to excessive aldosterone production, offering an effective alternative to current treatments by targeting the root cause of the condition. (S)-Baxdrostat’s specificity provides a promising approach to managing cardiovascular diseases.